YBGJ Stock Overview
Through its subsidiaries, focuses on the research and development and application of endometrial stem cells. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Yubo International Biotech Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.05 |
| 52 Week High | US$1.37 |
| 52 Week Low | US$0.031 |
| Beta | 0.66 |
| 1 Month Change | -38.62% |
| 3 Month Change | -43.50% |
| 1 Year Change | -83.43% |
| 3 Year Change | -89.07% |
| 5 Year Change | n/a |
| Change since IPO | -98.45% |
Recent News & Updates
Recent updates
Shareholder Returns
| YBGJ | US Biotechs | US Market | |
|---|---|---|---|
| 7D | -0.6% | -3.6% | -2.4% |
| 1Y | -83.4% | -2.7% | 23.3% |
Return vs Industry: YBGJ underperformed the US Biotechs industry which returned -1.5% over the past year.
Return vs Market: YBGJ underperformed the US Market which returned 22.1% over the past year.
Price Volatility
| YBGJ volatility | |
|---|---|
| YBGJ Average Weekly Movement | 71.9% |
| Biotechs Industry Average Movement | 10.8% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: YBGJ's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: YBGJ's weekly volatility has increased from 60% to 72% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 18 | Yang Wang | www.yubogroup.com |
Yubo International Biotech Limited, through its subsidiaries, focuses on the research and development and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is headquartered in Beijing, China.
Yubo International Biotech Limited Fundamentals Summary
| YBGJ fundamental statistics | |
|---|---|
| Market cap | US$5.96m |
| Earnings (TTM) | -US$2.00m |
| Revenue (TTM) | US$25.77k |
231.1x
P/S Ratio-3.0x
P/E RatioIs YBGJ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| YBGJ income statement (TTM) | |
|---|---|
| Revenue | US$25.77k |
| Cost of Revenue | US$221.28k |
| Gross Profit | -US$195.51k |
| Other Expenses | US$1.81m |
| Earnings | -US$2.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.017 |
| Gross Margin | -758.56% |
| Net Profit Margin | -7,771.52% |
| Debt/Equity Ratio | 0% |
How did YBGJ perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 14:20 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Yubo International Biotech Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|